With Hotuna, while the stock was trading I didnt mind whatsoever the input from a naysayer perspective. In fact very welcomed! but I do have issue now. Go blow someone else
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%